ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

Congressman Requests GAO Inquiry into FDA Foreign Inspections

April 19, 1996

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995

NCI Records Clear Flood Of Intervention For Man Accused Of Illegal Payoffs

February 3, 1978

NCI Should Enhance Funding Of Centers Program, Porter Says

July 12, 1991

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

January 30, 2009

Waxman urges drug companies to list clinical trials on NIH Web site.

June 18, 2004